How to Read a Clinical Trial Agreement
Budgets, Subject Injury, Indemnity, Data, Publication Rights and Termination Between Sponsor and Site, Clause by Clause, With a Fully Worked Case
-
- $15.99
-
- $15.99
Publisher Description
A clinical trial agreement is the contract by which a drug company, often through a contract research organization, pays a hospital or a university to run its study. It decides what the site is paid and when, who pays when a participant is injured, who owns the data and the inventions, whether the site may publish, and what happens if the study stops. This guide reads that contract the way a site contracts manager, a biotech finance or operations lead, a junior lawyer or an analyst needs to.
How to Read a Clinical Trial Agreement goes through who signs and what is attached; the good clinical practice, FDA and IRB rules the contract builds in; the budget, from per-participant fees, overhead and start-up fees to screen failures, pass-through costs, payment terms and the holdback; subject injury and the Medicare link; indemnification, insurance and limits of liability; study data, samples and inventions; publication rights, review periods and results reporting; the investigator's records, monitoring, audits and inspections; termination and close-out; and HIPAA authorization, financial disclosure and Open Payments. One fictional Phase 2 site file is followed from the first draft in Month 1 to the publication of the site's own paper in Month 43.
What is inside:
- 12 chapters, from why the site contract matters to the complete case, clause by clause
- A fully worked case, Veldtman Therapeutics and Penhallow University Hospital: a payment of $18,432 per completed participant ($14,400 of direct cost plus 28 percent overhead); a $25,000 start-up fee; a holdback of $73,728 on 40 participants; a total value of $1,028,720 if all 40 complete; a break-even of 24 participants and a site result of +$68,280, +$3,768 or -$44,616 depending on enrollment; a $38,600 hospital bill for an injured participant; a $2,500,000 claim tested against $5,000,000 and $2,000,000 insurance limits; and a study stopped in Month 18 that settles at $354,200
- A reading checklist of 40 questions
- 8 example clauses written for the book, each with a plain-English annotation
- A glossary of 50 terms
Written for clinical research contract managers at hospitals and universities, for clinical operations and finance leads at biotechs, for CRO project managers, for lawyers new to life sciences, for investigators and for analysts who read the exhibits of a biotech filing. The example clauses, the case, its companies, people, contracts, amounts, dates and figures are written for this book; the fees, overhead rates, costs, insurance limits and months are fictional teaching assumptions, not market data, and no clause is taken from any real agreement. Laws, rules, guidelines and filed agreements are paraphrased and cited as of the dates given in the book. This book is for education only and is not legal, medical, investment, tax, accounting or regulatory advice. No regulator, hospital, university, company or law firm has reviewed or endorsed it.
How this book was made: written with the help of artificial intelligence tools, under the author's direction; every figure was checked against its source.